Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001698493-17-000001
Filing Date
2017-02-22
Accepted
2017-02-22 12:55:47
Documents
1
Effectiveness Date
2017-02-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4769
  Complete submission text file 0001698493-17-000001.txt   5823
Mailing Address 1101 E. 33RD ST SUITE B301 BALTIMORE MD 21218
Business Address 1101 E. 33RD ST SUITE B301 BALTIMORE MD 21218 4107109674
Insilico Medicine, Inc. (Filer) CIK: 0001698493 (see all company filings)

EIN.: 465061086 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-281111 | Film No.: 17627676